Milestone Scientific Reports Increased Quarterly Loss

Milestone Scientific Inc ( (MLSS) ) has released its Q1 earnings. Here is a breakdown of the information Milestone Scientific Inc presented to its investors.

Milestone Scientific Inc. is a Delaware-based company specializing in the development of computer-controlled anesthetic delivery devices for dental and medical applications, with a focus on innovative technologies like the CompuFlo Epidural System. The latest earnings report for the quarter ended March 31, 2025, reveals a challenging period for Milestone Scientific, as the company experienced a net loss of approximately $2 million, compared to a $1.4 million loss in the same quarter of the previous year. Despite steady product sales of $2.2 million, the company faced increased operating expenses, particularly in research and development, and selling, general, and administrative costs. The company’s cash and cash equivalents decreased to $2.2 million from $3.3 million at the end of 2024, raising concerns about liquidity. However, management is implementing strategies to increase revenues and reduce costs, with a focus on expanding its dental business and medical device sales. Looking ahead, Milestone Scientific aims to achieve positive cash flow through increased revenue generation and cost management, although the company acknowledges the need for additional capital until profitability is achieved.